CLINICAL_TRIALS
trial_result
· 2022-07-08
Clinical Trial Update: Belimumab In Early Systemic Lupus Erythematosus [Phase 4]
Summary
Phase 4 clinical trial update for belimumab in early systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Lupus Erythematosus, Systemic | Phase 4 | Status: COMPLETED